Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)

60
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Merck KGaA May Withdraw Research from Portugal over Debt-Report

07/09/2012 | 02:28am US/Eastern

German chemical company Merck KGaA (>> Merck KGaA) may withdraw future investments for research projects in Portugal worth tens of millions of euros unless the government hospitals stick to the agreed-upon debt repayments, German daily newspaper Financial Times Deutschland reports Monday.

Merck Portugal's manager Fritz Sacher told the paper the company's research projects are long-term and require mutual trust as a basis. "The Portuguese government's lacking payment habits undermine this trust," he is quoted as saying.

Portuguese government hospitals owe the pharmaceutical industry a total of more than 1.5 billion euros ($1.84 billion) and companies have to wait nearly 550 days on average until invoices are paid, FTD reports.

Some companies, including Roche Holding AG (ROG.VX), have already halted the sale of medications on credit to highly indebted countries like Portugal, Greece, Spain and Italy until outstanding debts are paid, the paper notes, but for many companies such drastic steps are difficult as they carry responsibility for people's wellbeing.

Withdrawing research projects is a way of putting pressure on the government, as Portugal is an attractive location for research investments, FTD says. "The conditions for certain research and human studies are as good as in the U.S., but it's significantly more cost-effective in Portugal," Sacher told the paper.

Newspaper website: http://www.ftd.de

Write to the Frankfurt Bureau at djnews.frankfurt@dowjones.com

Stocks mentioned in the article : Merck KGaA
React to this article
Latest news on MERCK KGAA
07/02 MERCK KGAA : Researchers Submit Patent Application, "Method of Preparing a Biref..
07/01 MERCK KGAA : New Colon Cancer Findings from Merck KGaA Described (Phase I study ..
06/30 MERCK KGAA : Serono Introduces New Eeva Test Version Aiming for Optimized Assist..
06/29 German Merck expanding presence in Israel with acquisitions
06/29 MERCK KGAA : To Fully Acquire Israeli Quantum Materials Company Qlight Nanotech
06/26DJA Makeover At The 'Other' Merck
06/24 MERCK KGAA : EMD Serono Announces EUR 1.2 million Grant for Fertility Innovation..
06/24 SIGMA ALDRICH : Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, ..
06/24 MERCK KGAA : EMD Millipore Expands Provantage® Biodevelopment Services with Addi..
06/24 MERCK KGAA : Findings from Merck KGaA in the Area of Pharmaceutical Research and..
Advertisement
Chart
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Income Statement Evolution
More Financials